-
AAAAI: Exclusive Breastfeeding Not Linked to Eczema Risk
drugs
February 26, 2019
Exclusive breastfeeding is not associated with the odds of general eczema diagnosis, but exclusive breastfeeding for three months or longer is associated with reduced odds of continued eczema at age 6.....
-
School Prep Includes Planning Allergy, Asthma Management
drugs
August 08, 2018
Allergies and asthma can make the start of the new school year a challenge for kids who aren't prepared to deal with flare-ups, an allergist warns.
-
Vaccine suppresses peanut allergies in mice
europeanpharmaceuticalreview
April 16, 2018
A vaccine may successfully turn off peanut allergy in mice, a new study shows.
-
AnaptysBio’s Mid-Stage Peanut Allergy Data Indicates Positive Results
biospace
March 28, 2018
Shares of AnaptysBio were climbing this morning after the company released positive interim data for its experimental peanut allergy treatment.
-
Allergy Therapeutics kicks off dosing in grass immunotherapy trial
pharmatimes
October 20, 2017
Allergy Therapeutics has begun dosing in a mid-stage trial designed to assess the dose-response and safety of its ultra-short course PQ Grass immunotherapy, which targets the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen.
-
EpiVax Signs First Commercial License for Tregitope Technology
en-cphi.cn
April 26, 2017
Providence-based biotechnology company EpiVax, Inc. ("EpiVax") has licensed its novel immune-modulating technology to an undisclosed global pharmaceutical company, for use in autoimmune disease and allergy.
-
Circassia stumbles with allergy treatments at clinical trial stage, again
pharmafile
April 19, 2017
Circassia has slumped at the Phase 2 clinical trial stage again, after its failure with a treatment for those with an allergy to cats. At that point...